fluoroscan ii microplate fluorometer Search Results


99
Thermo Fisher fluoroskan ascent fl microplate fluorescence reader
Fluoroskan Ascent Fl Microplate Fluorescence Reader, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pm28902448-321-8-14?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
fluoroskan ascent fl microplate fluorescence reader - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
ICN Biomedicals microplate reader fluoroskan ii version 4.0
Microplate Reader Fluoroskan Ii Version 4.0, supplied by ICN Biomedicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pm07592381-71-5-11?v=ICN+Biomedicals
Average 90 stars, based on 1 article reviews
microplate reader fluoroskan ii version 4.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GMI Inc fluorescent microplate reader labsystem fluoroskan ii
Fluorescent Microplate Reader Labsystem Fluoroskan Ii, supplied by GMI Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pmc04063962-74-24-30?v=GMI+Inc
Average 90 stars, based on 1 article reviews
fluorescent microplate reader labsystem fluoroskan ii - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Becton Dickinson fluorescent microplate reader
Fluorescent Microplate Reader, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pmc01077171-284-42-46?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
fluorescent microplate reader - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
STAGO GmbH fluoroskan ascent microplate reader
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Fluoroskan Ascent Microplate Reader, supplied by STAGO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pmc10548689-62-21-25?v=STAGO+GmbH
Average 90 stars, based on 1 article reviews
fluoroskan ascent microplate reader - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Titertek Instruments microplate reader
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Microplate Reader, supplied by Titertek Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/10__1182_slash_blood__v91__7__2508-56-21-20?v=Titertek+Instruments
Average 90 stars, based on 1 article reviews
microplate reader - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Titertek Instruments fluorescence microplate reader
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Fluorescence Microplate Reader, supplied by Titertek Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pmc05363890-63-30-33?v=Titertek+Instruments
Average 90 stars, based on 1 article reviews
fluorescence microplate reader - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Titertek Instruments fluorescence microplate reader titertek fluoroscan
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Fluorescence Microplate Reader Titertek Fluoroscan, supplied by Titertek Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pmc05584207-123-18-21?v=Titertek+Instruments
Average 90 stars, based on 1 article reviews
fluorescence microplate reader titertek fluoroscan - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Labsystems Diagnostics Oy fluoroskan ascent fl microplate fluorometer
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Fluoroskan Ascent Fl Microplate Fluorometer, supplied by Labsystems Diagnostics Oy, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pmc11860464-218-49-54?v=Labsystems+Diagnostics+Oy
Average 90 stars, based on 1 article reviews
fluoroskan ascent fl microplate fluorometer - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

99
Thermo Fisher fluoroskan ascent microplate fluorometer
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Fluoroskan Ascent Microplate Fluorometer, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pm26928356-107-9-13?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
fluoroskan ascent microplate fluorometer - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

86
Fisher Scientific fluoroskan ascent microplate fluorometer
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Fluoroskan Ascent Microplate Fluorometer, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pm40784181-57-5-9?v=Fisher+Scientific
Average 86 stars, based on 1 article reviews
fluoroskan ascent microplate fluorometer - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Labsystems Diagnostics Oy fluorescent microplate reader labsystems fluoroskan
IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT <t>microplate</t> reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.
Fluorescent Microplate Reader Labsystems Fluoroskan, supplied by Labsystems Diagnostics Oy, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluoroscan+ii+microplate+fluorometer/pm31375080-95-14-19?v=Labsystems+Diagnostics+Oy
Average 90 stars, based on 1 article reviews
fluorescent microplate reader labsystems fluoroskan - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT microplate reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.

Journal: Thrombosis Journal

Article Title: Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm

doi: 10.1186/s12959-023-00549-5

Figure Lengend Snippet: IFE of AMC fluorophore and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilia plasma, or not, and was subsequently premixed with the indicated concentrations of AMC prior to initiating coagulation with Ca 2+ and substrate. Raw fluorescent data were produced by the CAT microplate reader and software and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS software, our in-house OR software, which uses published algorithms similar to CAT calibration, or SH software, our second in-house app based on CAT algorithm. An asterisk (*) next to the indicated concentrations in panels G & H denotes high AMC concentrations in which commercial TS software did not report TG curves, possibly due to their noisy appearance as suggested by the TG curves reported by OR and SH software apps at these high concentrations. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic sample and normalized hemophilia sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of AMC at indicated concentrations, 20 µL of PPP trigger, and 20 µL of FluCa.

Article Snippet: The experiment was then initiated by injection of the mixture of provided Fluo-Substrate and Fluo-Buffer (i.e., FluCa reagent mixture) using a Fluoroskan Ascent microplate reader (Stago).

Techniques: Coagulation, Produced, Software, Fluorescence, Concentration Assay

Substrate consumption and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilic plasma, or not, and was subsequently premixed with the indicated concentrations of substrate, ZGGR-AMC, prior to initiating coagulation with Ca 2+ and substrate. Raw data was produced by the CAT microplate reader and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curves data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS, OR or SH apps all of which employed the same CAT correction algorithm. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic and normalized sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of substrate ZGGR-AMC (at indicated concentrations), 20 µL of PPP trigger, and 20 µL of Ca 2+ (calcium chloride buffer)

Journal: Thrombosis Journal

Article Title: Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm

doi: 10.1186/s12959-023-00549-5

Figure Lengend Snippet: Substrate consumption and its correction via calibration or normalization. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilic plasma, or not, and was subsequently premixed with the indicated concentrations of substrate, ZGGR-AMC, prior to initiating coagulation with Ca 2+ and substrate. Raw data was produced by the CAT microplate reader and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-uncalibrated curves, (G, H) calibrated TG curves (via TS software), (I, J) calibrated TG curves (via OR software), and (L, M) calibrated TG curves (via SH software). Uncalibrated curves data were produced by differentiating the AMC curves observed in (A, B) . Calibrated curves were produced using TS, OR or SH apps all of which employed the same CAT correction algorithm. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic and normalized sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40 min. Assay conditions: 63 µL of FVIII-DP, 1 µL of FVIII (1 IU/mL), 16 µL of substrate ZGGR-AMC (at indicated concentrations), 20 µL of PPP trigger, and 20 µL of Ca 2+ (calcium chloride buffer)

Article Snippet: The experiment was then initiated by injection of the mixture of provided Fluo-Substrate and Fluo-Buffer (i.e., FluCa reagent mixture) using a Fluoroskan Ascent microplate reader (Stago).

Techniques: Coagulation, Produced, Fluorescence, Software, Concentration Assay

An attempt to study substrate consumption in plasma samples supplemented with two substrates, ZGGR-AMC and ZGGR-AFC. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilic plasma, or not, and was subsequently premixed with the indicated concentrations of two substrates, ZGGR-AMC and ZGGR-AFC, such that the ratio of AMC:AFC equaled to a concentration of 800 µM, prior to initiating coagulation with Ca 2+ . Raw data was produced by the Biotek microplate reader and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) Normalized-Uncalibrated curves, (G, H) Calibrated TG curves (via OR software), and (I, J) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . CAT calibrated curves were produced using our in-house OR and SH software apps, which use published algorithms similar to CAT calibration. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic and normalized sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. An artifact resembling TG signal in early minutes in Fig. 5 is only seen with ZGGR-AFC experiments, suggesting that it is caused by either the AFC fluorophore itself (similar to Fig. and Fig. S1 discussed above) or background fluorescence signal of un-cleaved ZGG-AFC substrate. Assay conditions: 78 µL of FVIII-DP, 2 µL of FVIII (1 IU/mL), 20 µL of PPP trigger, and 20 µL of custom FluCa mixtures (substrates ZGGR-AMC and ZGGR-AFC at indicated concentrations with calcium chloride buffer)

Journal: Thrombosis Journal

Article Title: Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm

doi: 10.1186/s12959-023-00549-5

Figure Lengend Snippet: An attempt to study substrate consumption in plasma samples supplemented with two substrates, ZGGR-AMC and ZGGR-AFC. FVIII-DP was supplemented with 1 IU/mL FVIII to normalize hemophilic plasma, or not, and was subsequently premixed with the indicated concentrations of two substrates, ZGGR-AMC and ZGGR-AFC, such that the ratio of AMC:AFC equaled to a concentration of 800 µM, prior to initiating coagulation with Ca 2+ . Raw data was produced by the Biotek microplate reader and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) Normalized-Uncalibrated curves, (G, H) Calibrated TG curves (via OR software), and (I, J) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . CAT calibrated curves were produced using our in-house OR and SH software apps, which use published algorithms similar to CAT calibration. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic and normalized sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 40–60 min. An artifact resembling TG signal in early minutes in Fig. 5 is only seen with ZGGR-AFC experiments, suggesting that it is caused by either the AFC fluorophore itself (similar to Fig. and Fig. S1 discussed above) or background fluorescence signal of un-cleaved ZGG-AFC substrate. Assay conditions: 78 µL of FVIII-DP, 2 µL of FVIII (1 IU/mL), 20 µL of PPP trigger, and 20 µL of custom FluCa mixtures (substrates ZGGR-AMC and ZGGR-AFC at indicated concentrations with calcium chloride buffer)

Article Snippet: The experiment was then initiated by injection of the mixture of provided Fluo-Substrate and Fluo-Buffer (i.e., FluCa reagent mixture) using a Fluoroskan Ascent microplate reader (Stago).

Techniques: Concentration Assay, Coagulation, Produced, Fluorescence, Software

Effect of CAT calibration on TG curves in procoagulant plasma samples. Antithrombin deficient plasma (ATIII-DP) was treated with or without heparin and the indicated TF concentration to assess the effect of calibration via different software apps in procoagulant samples. Raw data was produced by the CAT assay microplate reader and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-Uncalibrated curves, (G, H) calibrated TG curves (via CBER algorithm), and (I, J) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . CAT calibrated curves were produced by our in-house OR and SH software apps. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic and normalized sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 60 min. Assay conditions: ATIII-DP with 0.2 U/mL of normal pooled plasma with or without heparin (0.03 USP/mL), TF (0.12–20 pM), tPA (0.13 µg/mL), thrombomodulin (12.5 nM), PC:PS vesicles (4 µM) and custom FluCa mixture (800 µM ZGGR-AMC and calcium chloride)

Journal: Thrombosis Journal

Article Title: Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm

doi: 10.1186/s12959-023-00549-5

Figure Lengend Snippet: Effect of CAT calibration on TG curves in procoagulant plasma samples. Antithrombin deficient plasma (ATIII-DP) was treated with or without heparin and the indicated TF concentration to assess the effect of calibration via different software apps in procoagulant samples. Raw data was produced by the CAT assay microplate reader and analyzed in several different ways: (A, B) raw AMC fluorescence in relative fluorescent units (RFU), (C, D) internally calibrated TG curves via a thrombin calibration coefficient (see Materials and Methods), (E, F) normalized-Uncalibrated curves, (G, H) calibrated TG curves (via CBER algorithm), and (I, J) calibrated TG curves (via SH software). Uncalibrated curve data were produced by differentiating the AMC curves observed in (A, B) . CAT calibrated curves were produced by our in-house OR and SH software apps. Normalized-uncalibrated curves were produced by normalizing each uncalibrated curve pairing of hemophilic and normalized sample (hemophilic plasma supplemented with FVIII) at each pre-spiked AMC concentration against the TPH value of the normalized plasma sample in each pairing. TG was recorded for 60 min. Assay conditions: ATIII-DP with 0.2 U/mL of normal pooled plasma with or without heparin (0.03 USP/mL), TF (0.12–20 pM), tPA (0.13 µg/mL), thrombomodulin (12.5 nM), PC:PS vesicles (4 µM) and custom FluCa mixture (800 µM ZGGR-AMC and calcium chloride)

Article Snippet: The experiment was then initiated by injection of the mixture of provided Fluo-Substrate and Fluo-Buffer (i.e., FluCa reagent mixture) using a Fluoroskan Ascent microplate reader (Stago).

Techniques: Concentration Assay, Software, Produced, Fluorescence